dr. hussain on the rationale to target the dna repair pathway in mcrpc
Published 3 years ago • 87 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:18
dr. hussain on the clinical impact of the profound trial in mcrpc
-
1:33
dr. hussain on the implications of the profound trial in mcrpc
-
1:13
dr. hussain on the importance of genomic profiling in mcrpc
-
7:33
extraction of heaped up damageous wax from both ears,patient regain hearing and was much pleased.
-
16:07
profound trial shows increased rpfs in mcrpc patients with brca1, brca2, and atm mutations
-
4:59
what happens when your dna is damaged? - monica menesini
-
3:39
dna damage response
-
10:11
mayo clinic q&a podcast: consider all ovarian cancer treatment options, including clinical trials
-
0:54
dr. oh on the importance of identifying dna damage repair mutations in prostate cancer
-
2:21
dr. hussain on the treatment of nonmetastatic crpc
-
2:04
maha hussain, md, considers the role of homologous recombination repair in the management of mcrpc
-
4:25
the impact of dna repair defects on prostate cancer
-
4:12
parp inhibitors
-
1:27
dr. petrylak on pivotal parp inhibitor trials in mcrpc with dna repair mutations
-
1:01
dr. hussain on interest in using parp inhibitors in prostate cancer
-
12:24
the role of targeting dna repair with parp
-
21:13
treating aggressive prostate cancer with maha hussain, md
-
2:39
dr. hussain on ets gene fusions as a predictive biomarker in prostate cancer
-
3:53
homologous recombination repair pathway alterations in mhspc
-
3:49
the role of targeting dna repair mutations in advanced prostate cancer
-
3:52
first prostate cancer therapy to target genes delays cancer progression
-
1:32
dr. hussain discusses parp inhibitors in prostate cancer